Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3858363017 | Brolucizumab (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3858364011 | Brolucizumab | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4397361000052112 | brolucizumab | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Brolucizumab (substance) | Is a | Monoclonal antibody | true | Inferred relationship | Some | ||
| Brolucizumab (substance) | Has disposition (attribute) | Vascular endothelial growth factor receptor antagonist (disposition) | true | Inferred relationship | Some | ||
| Brolucizumab (substance) | Is a | Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Brolucizumab only product | Has active ingredient | True | Brolucizumab (substance) | Inferred relationship | Some | 1 |
| Brolucizumab-containing product | Has active ingredient | True | Brolucizumab (substance) | Inferred relationship | Some | 1 |
| Brolucizumab-containing product in parenteral dose form | Has active ingredient | True | Brolucizumab (substance) | Inferred relationship | Some | 1 |
| Product containing only brolucizumab in parenteral dose form (medicinal product form) | Has active ingredient | True | Brolucizumab (substance) | Inferred relationship | Some | 1 |
Reference Sets
Description inactivation indicator reference set
FHIR